by Nikki Borman, CEO, Borman & Company In a market that has a laser-focus around innovation targeted to battling the coronavirus, we’ve noticed a concerning lack of attention to research and invention in other categories. This applies not only to academia, where ongoing research has been stalled or sidelined, but also in the private sector where expertise is now redirected to the challenges of COVID-19. My point is not to say that the accelerated search for vaccines or effect